标题
Adjunctive Therapies to Optimize Closed-loop Glucose Control
作者
关键词
-
出版物
Journal of diabetes science and technology
Volume -, Issue -, Pages 193229682110327
出版商
SAGE Publications
发表日期
2021-07-28
DOI
10.1177/19322968211032701
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Fully Closed Loop Glucose Control With a Bihormonal Artificial Pancreas in Adults With Type 1 Diabetes: An Outpatient, Randomized, Crossover Trial
- (2021) Helga Blauw et al. DIABETES CARE
- Reducing the need for carbohydrate counting in type 1 diabetes using closed‐loop automated insulin delivery (artificial pancreas) and empagliflozin: A randomized, controlled, non‐inferiority, crossover pilot trial
- (2021) Ahmad Haidar et al. DIABETES OBESITY & METABOLISM
- Hybrid closed‐loop glucose control with faster insulin aspart compared with standard insulin aspart in adults with type 1 diabetes: A double‐blind, multicentre, multinational, randomized, crossover study
- (2021) Charlotte K. Boughton et al. DIABETES OBESITY & METABOLISM
- A Novel Dual-Hormone Insulin-and-Pramlintide Artificial Pancreas for Type 1 Diabetes: A Randomized Controlled Crossover Trial
- (2020) Ahmad Haidar et al. DIABETES CARE
- 198-OR: Individual Response of Automated Glycemic Control with the iLet Bionic Pancreas in the Insulin-Only vs. Bihormonal Configuration with the Stable Glucagon Analog Dasiglucagon
- (2020) JORDAN SHERWOOD et al. DIABETES
- 234-OR: Postprandial Glucose Control Using the Medtronic Advanced Hybrid Closed-Loop System: Faster-Acting Insulin Aspart vs. Insulin Aspart
- (2020) MELISSA H. LEE et al. DIABETES
- Effect of Afrezza on Glucose Dynamics During HCL Treatment
- (2020) Alfonso Galderisi et al. DIABETES CARE
- Fast-Acting Insulin Aspart Use with the MiniMed™ 670G System
- (2020) Liana J Hsu et al. Diabetes Technology & Therapeutics
- Effects of Sotagliflozin Combined with Intensive Insulin Therapy in Young Adults with Poorly Controlled Type 1 Diabetes: The JDRF Sotagliflozin Study
- (2020) Bruce W Bode et al. Diabetes Technology & Therapeutics
- Dual-Hormone Closed-Loop System Using a Liquid Stable Glucagon Formulation Versus Insulin-Only Closed-Loop System Compared With a Predictive Low Glucose Suspend System: An Open-Label, Outpatient, Single-Center, Crossover, Randomized Controlled Trial
- (2020) Leah M. Wilson et al. DIABETES CARE
- Real-World Patient-Reported Outcomes and Glycemic Results with Initiation of Control-IQ Technology
- (2020) Jordan E. Pinsker et al. Diabetes Technology & Therapeutics
- Fast acting insulin aspart Compared to Insulin aspart in the Medtronic 670G Hybrid Closed Loop System in Type 1 Diabetes: An Open Label Crossover Study.
- (2020) Kerem Ozer et al. Diabetes Technology & Therapeutics
- Effect of dapagliflozin as an adjunct to insulin over 52 weeks in individuals with type 1 diabetes: post-hoc renal analysis of the DEPICT randomised controlled trials
- (2020) Per-Henrik Groop et al. Lancet Diabetes & Endocrinology
- ADO09 , a co‐formulation of the amylin analogue pramlintide and the insulin analogue A21G , lowers postprandial blood glucose versus insulin lispro in type 1 diabetes
- (2020) Grit Andersen et al. DIABETES OBESITY & METABOLISM
- Add‐on therapy with dapagliflozin under full closed loop control improves time in range in adolescents and young adults with type 1 diabetes: The DAPADream study
- (2020) Torben Biester et al. DIABETES OBESITY & METABOLISM
- Overweight and obesity in type 1 diabetes equal those of the general population
- (2019) Paul Fellinger et al. WIENER KLINISCHE WOCHENSCHRIFT
- Metformin in 2019
- (2019) James Flory et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Metformin Improves Peripheral Insulin Sensitivity in Youth with Type 1 Diabetes
- (2019) Melanie Cree-Green et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Liraglutide in Children and Adolescents with Type 2 Diabetes
- (2019) William V. Tamborlane et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range
- (2019) Tadej Battelino et al. DIABETES CARE
- Realizing a Closed-Loop (Artificial Pancreas) System for the Treatment of Type 1 Diabetes
- (2019) Rayhan A Lal et al. ENDOCRINE REVIEWS
- One Year Clinical Experience of the First Commercial Hybrid Closed-Loop
- (2019) Rayhan A. Lal et al. DIABETES CARE
- Long‐term real‐life glycaemic outcomes with a hybrid closed‐loop system compared with sensor‐augmented pump therapy in patients with type 1 diabetes
- (2019) Halis Kaan Akturk et al. DIABETES OBESITY & METABOLISM
- Sotagliflozin in Combination With Optimized Insulin Therapy in Adults With Type 1 Diabetes: The North American inTandem1 Study
- (2018) John B. Buse et al. DIABETES CARE
- Overnight Glucose Control with Dual- and Single-Hormone Artificial Pancreas in Type 1 Diabetes with Hypoglycemia Unawareness: A Randomized Controlled Trial
- (2018) Alexander Abitbol et al. Diabetes Technology & Therapeutics
- Artificial pancreas treatment for outpatients with type 1 diabetes: systematic review and meta-analysis
- (2018) Eleni Bekiari et al. BMJ-British Medical Journal
- Artificial pancreas treatment for outpatients with type 1 diabetes: systematic review and meta-analysis
- (2018) Eleni Bekiari et al. BMJ-British Medical Journal
- Control of Postprandial Hyperglycemia in Type 1 Diabetes by 24-Hour Fixed-Dose Coadministration of Pramlintide and Regular Human Insulin: A Randomized, Two-Way Crossover Study
- (2018) Matthew C. Riddle et al. DIABETES CARE
- Home use of a bihormonal bionic pancreas versus insulin pump therapy in adults with type 1 diabetes: a multicentre randomised crossover trial
- (2017) Firas H El-Khatib et al. LANCET
- Effects of Sotagliflozin Added to Insulin in Patients with Type 1 Diabetes
- (2017) Satish K. Garg et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of artificial pancreas systems on glycaemic control in patients with type 1 diabetes: a systematic review and meta-analysis of outpatient randomised controlled trials
- (2017) Alanna Weisman et al. Lancet Diabetes & Endocrinology
- Efficacy of dual-hormone artificial pancreas to alleviate the carbohydrate-counting burden of type 1 diabetes: A randomized crossover trial
- (2016) V. Gingras et al. DIABETES & METABOLISM
- Mitigating Meal-Related Glycemic Excursions in an Insulin-Sparing Manner During Closed-Loop Insulin Delivery: The Beneficial Effects of Adjunctive Pramlintide and Liraglutide
- (2016) Jennifer L. Sherr et al. DIABETES CARE
- Performance and safety of an integrated bihormonal artificial pancreas for fully automated glucose control at home
- (2016) H. Blauw et al. DIABETES OBESITY & METABOLISM
- The efficacy and safety of DPP4 inhibitors in patients with type 1 diabetes: A systematic review and meta-analysis
- (2016) Heming Guo et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Dapagliflozin as Additional Treatment to Liraglutide and Insulin in Patients With Type 1 Diabetes
- (2016) Nitesh D. Kuhadiya et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Single- and Dual-Hormone Artificial Pancreas for Overnight Glucose Control in Type 1 Diabetes
- (2016) Ahmad Haidar et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Day and night glycaemic control with a bionic pancreas versus conventional insulin pump therapy in preadolescent children with type 1 diabetes: a randomised crossover trial
- (2016) Steven J Russell et al. Lancet Diabetes & Endocrinology
- Effect of Repeated Glucagon Doses on Hepatic Glycogen in Type 1 Diabetes: Implications for a Bihormonal Closed-Loop System
- (2015) Jessica R. Castle et al. DIABETES CARE
- Effect of Metformin Added to Insulin on Glycemic Control Among Overweight/Obese Adolescents With Type 1 Diabetes
- (2015) Ingrid M. Libman et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Outpatient overnight glucose control with dual-hormone artificial pancreas, single-hormone artificial pancreas, or conventional insulin pump therapy in children and adolescents with type 1 diabetes: an open-label, randomised controlled trial
- (2015) Ahmad Haidar et al. Lancet Diabetes & Endocrinology
- Quantification of the Glycemic Response to Microdoses of Subcutaneous Glucagon at Varying Insulin Levels
- (2014) Joseph El Youssef et al. DIABETES CARE
- Autonomous and Continuous Adaptation of a Bihormonal Bionic Pancreas in Adults and Adolescents With Type 1 Diabetes
- (2014) Firas H. El-Khatib et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Outpatient Glycemic Control with a Bionic Pancreas in Type 1 Diabetes
- (2014) Steven J. Russell et al. NEW ENGLAND JOURNAL OF MEDICINE
- Glucose-responsive insulin and glucagon delivery (dual-hormone artificial pancreas) in adults with type 1 diabetes: a randomized crossover controlled trial
- (2013) A. Haidar et al. CANADIAN MEDICAL ASSOCIATION JOURNAL
- Feasibility of a Portable Bihormonal Closed-Loop System to Control Glucose Excursions at Home Under Free-Living Conditions for 48 Hours
- (2013) Arianne C. van Bon et al. Diabetes Technology & Therapeutics
- Stable Liquid Glucagon Formulations for Rescue Treatment and Bi-Hormonal Closed-Loop Pancreas
- (2012) Melanie A. Jackson et al. Current Diabetes Reports
- Effect of Pramlintide on Prandial Glycemic Excursions During Closed-Loop Control in Adolescents and Young Adults With Type 1 Diabetes
- (2012) S. A. Weinzimer et al. DIABETES CARE
- GLP-1 receptor agonists for individualized treatment of type 2 diabetes mellitus
- (2012) Juris J. Meier Nature Reviews Endocrinology
- Minireview: Glucagon in the Pathogenesis of Hypoglycemia and Hyperglycemia in Diabetes
- (2011) Philip E. Cryer ENDOCRINOLOGY
- Biology of Human Sodium Glucose Transporters
- (2011) Ernest M. Wright et al. PHYSIOLOGICAL REVIEWS
- The use of metformin in type 1 diabetes: a systematic review of efficacy
- (2010) S. Vella et al. DIABETOLOGIA
- A Bihormonal Closed-Loop Artificial Pancreas for Type 1 Diabetes
- (2010) F. H. El-Khatib et al. Science Translational Medicine
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started